Re: “PICALM Gene rs3851179 Polymorphism Contributes to Alzheimer’s Disease in an Asian Population”

NeuroMolecular Medicine

Volumn 18, Issue 2, 2016, Pages 155-156

  Wang, Ming Jie ^a   Liu, Rui Ping ^a   Kong, Zhi Jun ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Alzheimer s disease; Meta analysis; PICALM; rs3851179 polymorphism

Indexed keywords

ALZHEIMER DISEASE; ASIAN; CHINA; DNA POLYMORPHISM; GENE; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC HETEROGENEITY; HUMAN; JAPAN; LETTER; OBSERVATIONAL STUDY; PICALM GENE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; STATISTICAL ANALYSIS; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION; GENETICS; SINGLE NUCLEOTIDE POLYMORPHISM;

CLATHRIN ASSEMBLY PROTEIN; PICALM PROTEIN, HUMAN;

ALZHEIMER DISEASE; ASIAN CONTINENTAL ANCESTRY GROUP; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MONOMERIC CLATHRIN ASSEMBLY PROTEINS; POLYMORPHISM, SINGLE NUCLEOTIDE;

EID: 84961168608     PISSN: 15351084     EISSN: 15591174     Source Type: Journal    
DOI: 10.1007/s12017-016-8387-9     Document Type: Letter

References (5)

1. Dickersin, K., Scherer, R., & Lefebvre, C. (1994). Identifying relevant studies for systematic reviews. BMJ, 309(6964), 1286–1291.
2. Higgins, J. P., & Thompson, S. G. (2002). Quantifying heterogeneity in a meta-analysis. Statistics in Medicine, 21(11), 1539–1558. doi:10.1002/sim.1186.
3. Lemeshow, A. R., Blum, R. E., Berlin, J. A., Stoto, M. A., & Colditz, G. A. (2005). Searching one or two databases was insufficient for meta-analysis of observational studies. Journal of Clinical Epidemiology, 58(9), 867–873. doi:10.1016/j.jclinepi.2005.03.004.
4. Liu, G., Zhang, S., Cai, Z., Ma, G., Zhang, L., Jiang, Y., et al. (2013). PICALM gene rs3851179 polymorphism contributes to Alzheimer’s disease in an Asian population. NeuroMolecular Medicine, 15(2), 384–388. doi:10.1007/s12017-013-8225-2.
5. Ziegler, A., Van Steen, K., & Wellek, S. (2011). Investigating Hardy–Weinberg equilibrium in case–control or cohort studies or meta-analysis. Breast Cancer Research and Treatment, 128(1), 197–201. doi:10.1007/s10549-010-1295-z.